A new repository antimalarial agent, CI-564, used in a field trial in New Guinea.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008288:Malaria / Q000517:prevention & control*; D008875:Middle Aged; D009512:New Guinea; D013450:Sulfones / Q000008:administration & dosage*; D014227:Triazines / Q000008:administration & dosage*
D000962:Antimalarials; D013450:Sulfones; D014227:Triazines